• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Ibrutinib
    1 Drug classified under this active ingredient


    All the Active Ingredient Drugs

    Imbruvica
    Janssen
    RX
    partial basket chart
    Imbruvica

    Bruton’s Tyrosine Kinase Inhibitor. Ibrutinib 140 mg.
    ORAL CAPS: 90, 120.
    MCL: 560 mg (4× 140 mg caps.)×1/d.
    CLL: 420 mg (3 ×140 mg caps.)×1/d.
    Tmt. of adult pts. with (MCL) who have
    received at least one prior ther.
    This indication is based on overall
    response rate.
    An improv. in survival, dis.-related symp.
    has not been established.
    Tmt. of pts. with (CLL) who have received
    at least one prior ther.
    This indicat. is based on overall response
    rate.
    An improv. in survival, dis.-related symp.
    has not been established.
    C/I: None.

    CLOSE